SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950123-10-084596
Filing Date
2010-09-08
Accepted
2010-09-08 16:48:43
Documents
5
Period of Report
2010-09-03
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K w79759e8vk.htm 8-K 14793
2 EX-99.1 w79759exv99w1.htm EX-99.1 12657
3 GRAPHIC w79759w7975900.gif GRAPHIC 2780
4 GRAPHIC w79759w7975901.gif GRAPHIC 4231
5 GRAPHIC w79759w7975902.gif GRAPHIC 2883
  Complete submission text file 0000950123-10-084596.txt   43032
Mailing Address 2273 RESEARCH BLVD, SUITE 400 ROCKVILLE MD 20850
Business Address 2273 RESEARCH BLVD, SUITE 400 ROCKVILLE MD 20850 (301) 795-1800
Emergent BioSolutions Inc. (Filer) CIK: 0001367644 (see all company filings)

IRS No.: 141902018 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33137 | Film No.: 101062690
SIC: 2834 Pharmaceutical Preparations